As of 2024-12-12, the Relative Valuation of Codiak BioSciences, Inc. (CDAK) is (10.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 USD, the upside of Codiak BioSciences, Inc. based on Relative Valuation is -18057.4%.
The range of the Relative Valuation is (9.58) - (8.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (9.58) - (8.94) | (10.24) |
| Upside | -16912.2% - -15790.4% | -18057.4% |
| Date | P/E |